NCT01732120

Brief Summary

The purpose of this research study is to compare the effects on kidney function after performing the removal of a kidney tumor with or without clamping the blood vessels during surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 22, 2012

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2017

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

June 9, 2022

Completed
Last Updated

May 19, 2023

Status Verified

July 1, 2022

Enrollment Period

4.6 years

First QC Date

November 16, 2012

Results QC Date

March 9, 2022

Last Update Submit

July 19, 2022

Conditions

Keywords

off-clamppartial nephrectomyrenal cancer treatmentrenal ischemia

Outcome Measures

Primary Outcomes (2)

  • Percent Change From Baseline in eGFR

    Renal function following nephrectomy with and without clamping will be assessed using: percent change in eGFR from baseline to 3 months post nephrectomy.

    baseline and 3 months post nephrectomy

  • Percent Change From Baseline in Split Renal Function

    Renal function following nephrectomy with and without clamping will be assessed using: percent change in split renal function from baseline to 3 months post nephrectomy.

    baseline to 3 months post nephrectomy

Secondary Outcomes (8)

  • Percent of Observations With Positive Surgical Margins.

    at the time of nephrectomy

  • Estimated Blood Loss

    At the time of nephrectomy

  • Percent of Observations With Metastasis

    3 years

  • Operative Time Measured in Minutes.

    At the time of nephrectomy

  • Warm Ischemia Time Measured in Minutes.

    At the time of nephrectomy.

  • +3 more secondary outcomes

Study Arms (2)

Off-clamp partial nephrectomy

EXPERIMENTAL

Partial nephrectomy will be performed without clamping of the renal blood vessels.

Procedure: Off-clamp partial nephrectomy

Traditional partial nephrectomy

NO INTERVENTION

Partial nephrectomy will be performed with clamping of the renal blood vessels.

Interventions

Off-clamp partial nephrectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 and older.
  • Patients willing and able to sign consent.
  • Patients with an organ confined renal mass planning to undergo a robotic assisted partial nephrectomy (RAPN).
  • Patient with Karnofsky Performance Status (KPS) equal to or greater than 40.

You may not qualify if:

  • Patients under 18.
  • Patients with Karnofsky Performance Status (KPS) less than 40.
  • Patients with non-organ confined renal masses (invading renal vein, inferior vena cava, peri-renal tissue, ipsilateral adrenal gland, or metastasis).
  • Patients with bilateral synchronous renal masses.
  • Patients who can not discontinue Plavix, Coumadin or other anti-platelet or anti-coagulant medications.
  • Patients with renal lesions determined to be too complex to perform a RAPN without clamp by the surgeon. (The renal mass may be deemed too difficult based on pre-operatively radiological findings. The surgeon's decision to exclude a mass from a robotic assisted partial nephrectomy would be based on a higher risk of positive margin or complication if a RAPN was performed.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Kidney Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Results Point of Contact

Title
Manager of Clinical Trials
Organization
Washington University School of Medicine

Study Officials

  • Robert S Figenshau, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2012

First Posted

November 22, 2012

Study Start

November 1, 2012

Primary Completion

May 31, 2017

Study Completion

December 31, 2020

Last Updated

May 19, 2023

Results First Posted

June 9, 2022

Record last verified: 2022-07

Locations